A STUDY TO EVALUATE IF CRISABOROLE OINTMENT 2% WORKS WELL AND SAFE IN 2 YEARS AND OLDER CHINESE AND JAPANESE ECZEMA PATIENTS - Trial 2021-006538-38
Access comprehensive clinical trial information for 2021-006538-38 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2021-006538-38
Trial Details
EU Clinical Trials Register • 2021-006538-38
A STUDY TO EVALUATE IF CRISABOROLE OINTMENT 2% WORKS WELL AND SAFE IN 2 YEARS AND OLDER CHINESE AND JAPANESE ECZEMA PATIENTS
Study Focus
Sponsor & Location
Pfizer Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Daxiii;
ICD-10 Classifications
Atopic dermatitis
Atopic dermatitis, unspecified
Other atopic dermatitis
Acute atopic conjunctivitis
Allergic contact dermatitis
Data Source
EU Clinical Trials Register
2021-006538-38
Non-Device Trial